Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session of evolution of vaccination. We have Dr Srivastava and Dr Jaydeep Choudhury to lead the session.
It is well known to each one of us how the science of vaccine development has evolved starting from the invention of attenuated vaccines. We are also aware about the importance of vaccination for the children or neonates.
In this webinar, a more detailed discussion is provided on the development of 6-in-1 aP combination vaccine, its usage and its importance among the pediatric population.
The 6-in-1 aP combination vaccine is referred as DTaP/Hib/HepB/IPV, stands for 'Diphtheria, Tetanus, acellular Pertussis, Hib, Hepatitis B and Inactivated Polio Vaccine'. The advantage is one single vaccine can protect the child from the mentioned diseases and save the child from taking each of vaccines separately.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Some triple negative breast cancers might be avoided by longer breastfeeding
2.
The Effect of Common Steroids on Cancer Treatments.
3.
Gene therapies for BCG-unresponsive bladder cancer have high response rates.
4.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
5.
Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?
1.
Exploring the Latest Treatments for Desmoid Tumors
2.
The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment
3.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
4.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
5.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
Updates on the First Line Management of ALK+ NSCLC
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation